News

Leap Joins the Castlight Ecosystem to Simplify Infusion Care

Image

We’re excited to announce that Leap has joined the Castlight ecosystem—expanding the tools available to TPAs and employers working to manage one of the most complex and costly areas of a self-funded health plan: infusion therapy.

Infusion services impact a relatively small percentage of employees, yet they consistently rank among the highest—and least predictable—drivers of total plan spend. For TPAs and benefits leaders, this often means volatile claims, opaque markups across sites of care, and limited visibility into true net costs. At the same time, employees managing chronic or complex conditions face inconsistent access, logistical hurdles, and unnecessary disruption to their work and personal lives.

Our partnership with Castlight is designed to address these challenges at their root.

Transparent pricing that eliminates hidden margins

Leap’s pass-through pricing model provides full visibility into infusion costs. Rather than navigating variable facility fees or opaque buy-and-bill markups, TPAs, consultants, and employers gain clear line-of-sight into exactly what the plan is paying. The result is cleaner reporting, more accurate forecasting, and a trusted baseline for managing spend.

Predictable, lower net spend across sites of care

By aligning pricing to employer needs—not facility economics—Leap enables plans to guide members to the most clinically appropriate and cost-effective settings. This reduces unnecessary facility charges and delivers measurable savings without adding administrative burden for TPAs or internal benefits teams.

A better member experience with less friction

For employees undergoing infusion therapy, care is often complex enough without added barriers. Leap’s nationwide network and streamlined care coordination improve convenience, reduce disruption, and support adherence—leading to better outcomes and fewer downstream complications.

Strengthening a platform employers already rely on

Castlight’s navigation platform is widely trusted to guide employees to high-quality, high-value care. Integrating Leap’s specialized infusion solution enhances that experience, giving TPAs and benefits leaders a more complete and actionable way to manage one of the most challenging components of pharmacy and medical spend.

We’re proud to partner with Castlight to bring employers and their members a more predictable, transparent, and human-centered approach to infusion care.

Share this post

More insights

Image
Education

The Infusion Cost Crisis: Why Medical Benefit Drug Spend Keeps Escalating

For employers, however, infusion care has quietly become one of the fastest-growing and least unders...

Read article
Image
Insights

Rebates, what rebates? Understanding pharmacy rebates for J-Code drugs

Pharmacy rebates are manufacturer-paid discounts, typically negotiated behind

Read article
Image
Education

Demystifying Specialty Drug Pricing Acronyms, and Why They All Fail Employers

Behind the exorbitant costs of infusion therapies, you’ll find layers of complexity—and three acrony...

Read article
Image
Clinical

Safely Infusing Immunoglobulin in the Home Setting: Clinical Considerations and Best Practices

Immunoglobulin (Ig) therapies are essential in the treatment of primary immunodeficiency (PID), chro...

Read article
Image
News

Leap and Amwins Partner to Deliver Low-Cost, Convenient Infusion Therapy

Leap and Amwins Rx, today announced a strategic collaboration that will bring significant benefits t...

Read article
Image
Case Study

Bringing Relief Home for Annie

Helping a working parent stay on track with infusion care

Read article
Image
Insights

How Leap Reduces the Total Cost of Multiple Sclerosis Care

For patients requiring long-term MS infusions like Ocrevus or Tysabri, traditional hospital-based tr...

Read article
Image
News

Leap and Blackhawk Claims Service Partner to Reduce Specialty Medication Costs and Improve Patient Access

We're so excited to announce our strategic partnership with Blackhawk Claims Service, a leading thir...

Read article
Image
Insights

The High Cost of RA Infusions – and How Leap Fixes It

For many patients, biologic infusions such as Remicade, Actemra, and Orencia are essential but they ...

Read article
Image
Insights

Why Home Infusion Is Safe, Effective – and Preferred by Patients

More patients and employers are choosing home infusion as a safe, effective alternative to hospital-...

Read article